Skip to main content
. 2022 May 30;11(11):3079. doi: 10.3390/jcm11113079

Figure 1.

Figure 1

(a) A 41-year-old patient with invasive-ductal carcinoma (pT2 pN1a (3/3) M0) of the left breast and a BRCA-1 mutation after neo-adjuvant chemotherapy with mild volume asymmetry and breast ptosis grade II (Regnault classification). (b) Six years after the bilateral nipple sparing mastectomy and immediate subpectoral implant-based breast reconstruction (Motiva Ergonomix® ERSD 475 cc, Establishment Labs Motiva, Alajuela, Costa Rica) and ADM (Strattice™ tissue matrix, LifeCell Corporation; Branchburg, NJ, USA) through a periareolar access with lateral extension to correct the ptosis and adjuvant radiotherapy of the left breast. Note the rippling of the right breast (upper inner quadrant), skin retraction, and capsular contraction grade II (Baker classification) of the left breast.